- Home
- FUSB vs HYFT Comparison
FUSB vs HYFT Comparison
Compare FUSB & HYFT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | FUSB | HYFT |
|---|---|---|
| Founded | 1952 | 1983 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Major Banks | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 86.5M | 69.6M |
| IPO Year | 1995 | N/A |
Fundamental Metrics
Financial Performance| Metric | FUSB | HYFT |
|---|---|---|
| Price | $15.42 | $1.16 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 7.1K | ★ 390.8K |
| Earning Date | 04-29-2026 | 01-01-0001 |
| Dividend Yield | ★ 1.84% | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ 0.64 | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $51.71 |
| P/E Ratio | $24.09 | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $10.47 | $1.15 |
| 52 Week High | $15.99 | $3.00 |
Technical Indicators
Market Signals| Indicator | FUSB | HYFT |
|---|---|---|
| Relative Strength Index (RSI) | 57.40 | 30.86 |
| Support Level | $13.54 | N/A |
| Resistance Level | $15.99 | $2.17 |
| Average True Range (ATR) | 0.32 | 0.10 |
| MACD | -0.06 | -0.01 |
| Stochastic Oscillator | 81.96 | 4.73 |
Price Performance
Historical ComparisonAbout FUSB First US Bancshares Inc.
First US Bancshares Inc is a bank holding company. The Bank conducts general commercial banking business and offers banking services such as demand, savings, individual retirement account and time deposits, personal and commercial loans, safe deposit box services, and remote deposit capture. The Bank provides a range of commercial banking services to small and medium-sized businesses, property managers, business executives, professionals, and other individuals.
About HYFT MindWalk Holdings Corp.
MindWalk Holdings Corp is a Bio-Native AI company transforming drug discovery and development. Powered by patented HYFT technology and the LensAI platform, MindWalk unifies sequence, structure, function, and literature into a single computational language and closes the loop with an integrated, full-stack wet lab. The platform supports rapid epitope mapping, de novo molecular design, in silico vaccine exploration, and population-scale biologics analytics that help turn insights into validated candidates at speed.